The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2023 | Highlights from ELCC 2023 in lung cancer
Pilar Garrido Lopez, MD, PhD, University Hospital Ramón y Cajal, Madrid, Spain, expresses what she has been most interested to hear more on at the European Lung Cancer Congress (ELCC) 2023 in Copenhagen, Denmark. She notes the presentation of both positive and negative data pertaining to emerging therapies, debates around adjuvant and neo-adjuvant treatments, and approaches to uncommon molecular alterations as all being of significance. This interview took place at ELCC 2023 in Copenhagen, Denmark.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
